Tolerance to propofol's sedative effect in mechanically ventilated rabbits

Anesthesia and Analgesia

Volumn 103, Issue 2, 2006, Pages 359-365

  Ypsilantis, Petros ^a,c   Mikroulis, Dimitrios ^a   Politou, Maria ^a   Tsoukali, Heleni ^b   Pitiakoudis, Michail ^a   Didilis, Vasilios ^a   Theodoridis, Georgios ^b   Bougioukas, Georgios ^a   Simopoulos, Constantinos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL; SEDATIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AROUSAL; ARTERIAL BLOOD; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG INFUSION; DRUG TOLERABILITY; ENDOTRACHEAL INTUBATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLIC CLEARANCE RATE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEDATION; STEADY STATE; SURVIVAL;

EID: 33746506758     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000223684.76783.bf     Document Type: Article

References (16)

1. McKeage K, Perry CM. Propofol: a review of its use in intensive care sedation of adults. CNS Drugs 2003;17:235-72.
2. Buckley PM. Propofol in patients needing long-term sedation in intensive care: an assessment of the development of tolerance: a pilot study. Intensive Care Med 1997;23:969-74.
3. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth 1998;8:491-9.
4. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003;29:1417-25.
5. Albrecht S, Ihmsen H, Suchodolski K, et al. Analgo-sedation in intensive care: a quantitative, EEC-based trial with propofol 1% and 2%. Anaesthesist 1999;48:794-801.
6. Cohen Y, Feldinger E, Ogorek D, Weinbroum AA. Increased propofol requirement during succeeding administrations for electroconvulsive therapy. J Clin Anesth 2004;16:282-5.
7. Gronert G, Haskins S, Steffey E, Fung D. Plasma electrolyte and metabolite concentrations associated with pentobarbital or pentobarbital- propofol anesthesia during three weeks' mechanical ventilation and intensive care in dogs. Lab Anim Sci 1998;48:513-9.
8. Bernard N, Matecki S, Py G, et al. Effects of prolonged mechanical ventilation on respiratory muscle ultrastructure and mitochondrial respiration in rabbits. Intensive Care Med 2003;29:111-8.
9. Capdevila X, Lopez S, Bernard N, et al. Effects of controlled mechanical ventilation on respiratory muscle contractile properties in rabbits. Intensive Care Med 2003;29:103-10.
10. Khiabani KT, Kerrigan CL. A new protocol for prolonged general anesthesia in rabbits. Plast Reconstr Surg 1998;102:1787.
11. th ed. London: McGraw-Hill, 1996: 557-78.
12. Myburgh J, Upton R, Grant C, Martinez A. Epinephrine, norepinephrine and dopamine infusions decrease propofol concentrations during continuous propofol infusion in an ovine model. Intensive Care Med 2001;27:276-82.
13. Kurita T, Morita K, Kazama T, Sato S. Influence of cardiac output on plasma propofol concentrations during constant infusion in swine. Anesthesiology 2002;96:1498-503.
14. Kanto J, Gepts E. Pharmacokinetic implications for the clinical use of propofol. Clin Pharmacokinet 1989;17:308-26.
15. th edition. London: McGraw-Hill, 1996: 29-42.
16. Barr J, Egan TD, Sandoval NF, et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001;95:324-33.